CJC-1295(without DAC)+ Ipamorelin (5/5mg) — Dual Pathway GH Research
CJC-1295 is a GHRH analogue incorporating Drug Affinity Complex (DAC) technology for extended albumin binding, producing sustained GHRH receptor (GHRHR) activation on pituitary somatotrophs. Ipamorelin is a selective GHSR agonist — the most receptor-selective compound in the ghrelin mimetic class, with minimal off-target receptor activity at research concentrations.
The two compounds operate via distinct receptor systems: GHRHR (CJC-1295) and GHSR (Ipamorelin). Preclinical research has demonstrated that co-administration produces synergistic GH pulse amplitude compared to either compound in isolation. This dual-pathway approach is among the most-studied designs in growth hormone axis research.
For full mechanism, receptor pharmacology, and study summaries, see the CJC-1295(without DAC)+ Ipamorelin (5/5mg) Researchers Guide. For research use only.
CJC-1295(without DAC)+ Ipamorelin (5/5mg) Products
Pre-mixed blend supplied in boxes of 10 research-grade vials.
Why Researchers Choose Eternal Peptides Wholesale
Published Batch Reports
Review the published reports for the selected product and batch. Only the tests and results shown on those reports apply; do not assume additional methods or testing were performed.
Online Research Supplier
online Australian business Contact us about supplier and invoicing documentation before ordering.
Wholesale Box Pricing
Pre-mixed blend in boxes of 10 vials. No need to source and combine compounds separately. Research procurement pricing.
Processing & Delivery
Consult our Shipping Policy for processing and delivery estimates. Dispatch origin can vary, including offshore fulfilment; Australian business ownership does not guarantee domestic stock or customs-free delivery. View available reports on the product pages.
Frequently Asked Questions
Where can I buy CJC-1295(without DAC)+ Ipamorelin (5/5mg) in Australia? +
Eternal Peptides Wholesale is an Australian-owned, online distributor supplying CJC-1295(without DAC)+ Ipamorelin (5/5mg) for research purposes. CP10 (5mg/5mg, box of 10) is $643.50. Janoshik-verified with COA on product page. see Shipping Policy for dispatch estimates. For research use only.
Why are CJC-1295 and Ipamorelin combined? +
CJC-1295 stimulates GH release via the GHRH receptor; Ipamorelin via the GHSR. These are distinct, complementary pathways. Co-administration research has shown synergistic GH pulse amplitude compared to either compound alone — making the combination one of the most studied dual-pathway approaches in GH axis research. For research use only.
How does CJC-1295 differ from Sermorelin? +
Both are GHRH analogues acting at GHRHR. Sermorelin is the shorter GHRH(1-29) fragment with a shorter half-life suited to pulsatile release studies. CJC-1295 incorporates DAC technology for albumin binding, extending its half-life significantly for sustained release research designs. See the Sermorelin page. For research use only.
How is the blend quality verified? +
Review the published reports for the selected product and batch. Only the tests and results shown on those reports apply; do not assume additional methods or testing were performed.
How quickly is CP10 dispatched? +
Consult our Shipping Policy for processing and delivery estimates. Dispatch origin can vary, including offshore fulfilment; Australian business ownership does not guarantee domestic stock or customs-free delivery. View available reports on the product pages.